Our roundup of January's news that affects those managing diabetes themselves or as a carer.
NICE PUBLISHES DRAFT GUIDELINES FOR HYBRID LOOPS FOR T1DS
In January, NICE (National Institute for Clinical Excellence) published draft guidelines for recommending the use of hybrid loops for those living with type 1 diabetes. The proposed criteria is to offer this technology to PWD with HbA1c over 8.0%. This could mean that over 105,000 T1s in England benefit, including those pregnant or planning pregnancy.
The consultation process ended on 31 January and we now wait to see if the guidelines are modified and approved.
More information is available here (external link).
TIDEPOOL GETS FDA CLEARANCE
Tidepool, a mobile app intended for use with a CGM to automate insulin dosing, has been cleared for marketing in the USA, by the FDA.
This is the first ever fully interoperable automated insulin dosing app, cleared by the FDA that began as a patient-led initiative ie. from the #WeAreNotWaiting community.
The app is approved for type 1 diabetes management in persons aged 6 years and older.
More information is on the Tidepool website. Click here (external link).
ABBOTT'S PLAN TO TACKLE DIABETES STIGMA
SIMS 4 GAME INCLUDES CGM OPTIONS
An update to the life simulation game, Sims 4, available for PlayStation and Xbox, has included options for characters to wear medical devices such as CGMs.
Players can now choose a CGM form for their character giving the appearance of wearing a Dexcom, Freestyle Libre or other system.
DEXCOM G7 TO LAUNCH IN US
It's been confirmed by Dexcom that the G7 will launch in the US on 17 February 2023.
Find out what to expect with this new medtech device, read out blog 'What to expect' here.